In a clinical trial with nearly 1,000 participants, people on resmetirom were more likely to see improvement in their condition than those taking a placebo, researchers reported in the New England Journal of Medicine
Many of the most commonly reported symptoms including nausea, vomiting, and constipation mirror what participants report in clinical trials
That dual mechanism is part of why we see such meaningful results in clinical trials, with patients losing up to about 21 percent of their body weight when combined with lifestyle changes. While often associated with weight loss, Zepbound may also support better blood sugar, cholesterol and blood pressure levels, and it can even help manage conditions like fatty liver and sleep apnea, says Dr
Semaglutide operates by simulating an incretin hormone, which helps regulate blood sugar levels, thereby playing a critical role in the maintenance of type 2 diabetes
current clinical evidence shows no mechanism for cardiac atrophy and suggests potential cardiovascular benefits instead
